Common Cold
📧 Sign up to get email alerts when something new happens for Common Cold.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-09-26Clinical Trial Update: Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of Common Cold [Phase 3]
A Phase 3 trial evaluating the combination of acetylcysteine, paracetamol and phenylephrine for the common cold has been withdrawn. Sponsor:…
-
CLINICAL_TRIALS withdrawal · 2024-07-05Clinical Trial Update: Clinical Trial to Optimise Levels of Vitamin D for Rhinovirus Protection [Phase 2]
A Phase 2 clinical trial evaluating whether optimizing vitamin D levels can protect against rhinovirus-induced common cold was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-10-16Clinical Trial Update: Efficacy and Safety of Irlanda-1-Association on the Treatment of Common Cold in Children [Phase 3]
A Phase 3 trial evaluating Irlanda-1-Association for treating the common cold in children was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-10-16Clinical Trial Update: Efficacy and Safety of Irlanda-2 Association on the Treatment of Common Cold [Phase 3]
Phase 3 trial of Irlanda-2 Association for common cold was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-07-18Clinical Trial Update: Echinaforce Junior Bioavailability Trial [Phase 4]
Phase 4 trial of Echinaforce Junior for the common cold was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2018-03-12Clinical Trial Update: An Efficacy and Safety Study of Theraflu Day Powder as Oral Solution for Cold and Flu [Phase 3]
A Phase 3 clinical trial evaluating Theraflu Day Powder for cold and flu was withdrawn, indicating the program was terminated prior to compl…
-
CLINICAL_TRIALS withdrawal · 2018-03-12Clinical Trial Update: An Efficacy and Safety Study of Theraflu Night Powder as Oral Solution for Cold and Flu [Phase 3]
A Phase 3 trial evaluating Theraflu Night Powder as an oral solution for cold and flu has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-10-19Clinical Trial Update: Study Comparing 3 Formulations to Evaluate the Efficacy and Safety of the Inflammatory Symptoms of the Upper Respiratory Tract, in Children Between 2 and 6 Years Old [Phase 3]
A Phase 3 trial evaluating three formulations for inflammatory symptoms of the upper respiratory tract in children aged 2 to 6 has been with…
-
CLINICAL_TRIALS withdrawal · 2015-10-14Clinical Trial Update: Evaluation of the Efficacy and Safety of Two Ibuprofen Combination Products for the Treatment of the Common Cold and Flu in Latin America [Phase 3]
Pfizer withdrew a Phase 3 trial evaluating two ibuprofen combination products for the treatment of the common cold and influenza in Latin Am…